Probing the Role of Imidazopyridine and Imidazophosphorine Scaffolds To Design Novel Proton Pump Inhibitor for H+,K+-ATPase: A DFT Study
Sign Up to like & getrecommendations! Published in 2019 at "ACS Omega"
DOI: 10.1021/acsomega.8b02756
Abstract: Clinically used proton pump inhibitors (PPIs) are not perfectly suitable for prolonged acid suppression because of the short plasma half-lives of 1–1.5 h. However, tenatoprazole, an imidazopyridine... read more here.
Keywords: proton pump; probing role; role imidazopyridine; proton ... See more keywords